Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
3
Bullish
8
Bearish
24
Neutral
3
Bullish
19
Bearish
21
Neutral
0
Bullish
11
Bearish
3
Neutral
3
Bullish
8
Bearish
3
Neutral
3
Bullish
8
Bearish
21
Neutral
0
Bullish
11
Bearish
21
Neutral
0
Bullish
11
Bearish
21
Neutral
0
Bullish
11
Discovery themes featuring this stock
Crisil is a global, insights-driven analytics company (majority-owned by S&P Global) offering credit ratings, research, data, risk and analytics-led solutions across Ratings, Research & Advisory and global benchmarking businesses, serving over 11,400 clients across 40 countries and deploying domain expertise to support financial institutions, corporates and governments in mission-critical decisions.
Q1 FY26 showed a sharp acceleration: income from operations rose 30.1% year-on-year to ₹1,058 crore and PBT grew 35.7% to ₹308 crore, aided by an INR forex gain of ₹14.4 crore and accelerated contract renewals contributing roughly US$4.5 million of timing-related incremental revenue that is expected to normalise through the year.
Crisil is actively productising GenAI into domain-led commercial offerings — GenEye, DeepMine, Crisil i360, Credit+, ICON and Myron AI — and claims majority workforce adoption, supported by an AI governance framework and 26 industry recognitions, signalling a strategic pivot to AI-enabled, higher‑velocity client solutions and operational productivity.
Strategic inorganic moves and capacity expansion underpin growth: the PriceMetrix acquisition broadened Crisil's wealth management suite and entry into Canada, while Global Analytics Centre expansion and a new delivery centre in Colombia deepen global servicing and create cross-sell opportunities into S&P Global and regional banking clients.
Margins and segment mix have improved meaningfully in RAS: Q1 RAS revenues rose 34.9% and segment margins expanded to 22.7%, reflecting operating leverage from higher revenue, better mix and cost discipline; Crisil maintained market leadership in Ratings with surveillance-led revenue growth and healthy segment margins above 44% for Ratings.
Finance
Other Financial Services
33,669 Cr
Low Risk
38.1
17.9
1.8
10.3
5,060.00
3,689.00
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
4630.00 | 33,669 Cr | 38.07 | 10.29 | 1.30 | 27.03 | 33.10 | 17.60 | ||
72.17 | 2,029 Cr | 44.65 | 15.09 | 0.00 | 24.84 | 28.53 | 16.51 | ||
166.05 | 1,297 Cr | -1424.75 | 2.67 | 0.00 | 4.50 | 6.04 | -0.18 | ||
21.32 | 1,030 Cr | -3.19 | 3.66 | 0.00 | -99.44 | 6.93 | -1.50 | ||
298.00 | 1,005 Cr | 173.93 | 3.92 | 0.00 | 3.69 | 7.37 | 2.01 | ||
840.45 | 896 Cr | 27.34 | 5.95 | 0.12 | 25.69 | 34.22 | 18.20 | ||
995.20 | 555 Cr | 6932.00 | 6.89 | 0.02 | 27.26 | 36.88 | 44.81 | ||
| Median: 7 Co. | — | 298.00 | 1,030 Cr | 38.07 | 5.95 | 0.00 | 24.84 | 28.53 | 16.51 |
CRISIL Ltd (CRISIL) is currently trading at 4,496.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crisil is a global, insights-driven analytics company (majority-owned by S&P Global) offering credit ratings, research, data, risk and analytics-led solutions across Ratings, Research & Advisory and global benchmarking businesses, serving over 11,400 clients across 40 countries and deploying domain expertise to support financial institutions, corporates and governments in mission-critical decisions. Q1 FY26 showed a sharp acceleration: income from operations rose 30.1% year-on-year to ₹1,058 crore and PBT grew 35.7% to ₹308 crore, aided by an INR forex gain of ₹14.4 crore and accelerated contract renewals contributing roughly US$4.5 million of timing-related incremental revenue that is expected to normalise through the year. Crisil is actively productising GenAI into domain-led commercial offerings — GenEye, DeepMine, Crisil i360, Credit+, ICON and Myron AI — and claims majority workforce adoption, supported by an AI governance framework and 26 industry recognitions, signalling a strategic pivot to AI-enabled, higher‑velocity client solutions and operational productivity. Strategic inorganic moves and capacity expansion underpin growth: the PriceMetrix acquisition broadened Crisil's wealth management suite and entry into Canada, while Global Analytics Centre expansion and a new delivery centre in Colombia deepen global servicing and create cross-sell opportunities into S&P Global and regional banking clients. Margins and segment mix have improved meaningfully in RAS: Q1 RAS revenues rose 34.9% and segment margins expanded to 22.7%, reflecting operating leverage from higher revenue, better mix and cost discipline; Crisil maintained market leadership in Ratings with surveillance-led revenue growth and healthy segment margins above 44% for Ratings.
Over the past 52 weeks, CRISIL Ltd has traded between a low of ₹3,689.00 and a high of ₹5,060.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
CRISIL Ltd has a market capitalization of approximately 33,669.43. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
CRISIL Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 38.07 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33,669.43 Cr, CRISIL Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
CRISIL Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of CRISIL Ltd is 38.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The dataset reports Q2 FY26 consolidated revenue of ₹911.24 crore and consolidated PAT of ₹193.10 crore.
CRISIL reported consolidated revenue from operations of Rs 1,057.66 crore in Q1 FY26 and net profit (PAT) of Rs 233.26 crore.
Consolidated income from operations was ₹1,057.7 crore and profit after tax was ₹233.3 crore for the quarter ended March 31, 2026.
CRISIL reported consolidated revenue from operations of Rs 1,057.66 crore in Q1 FY26, up from Rs 813.18 crore in Q1 FY25.
